Gummy Smile and Altered Passive Eruption Prevalence
Italy100 participantsStarted 2025-09-01
Plain-language summary
This observational epidemiological study aims to assess the prevalence of gummy smile and altered passive eruption in a young adult population, with a focus on the second sextant. Periodontal and aesthetic parameters, along with patient-reported discomfort, will be analyzed to identify potential correlations and underlying anatomical factors.
Who can participate
Age range
18 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male and female subjects;
* Age between 18 and 50 years;
* Periodontally healthy subjects;
* Patients with no history of orthodontic treatment;
* Patients without gingival hypertrophy or hyperplasia.
Exclusion Criteria:
* Age \< 18 or \> 50 years;
* Patients diagnosed with Stage I-IV periodontitis;
* Patients currently undergoing orthodontic treatment;
* Patients with severe dental crowding in the second sextant;
* Patients taking medications associated with gingival hypertrophy or -hyperplasia;
* Patients unwilling to provide informed consent;
* Patients with fixed or removable prostheses in the second sextant;
* Patients with a history of surgical procedures in the second sextant;
* Patients with uncontrolled diabetes or neuropsychiatric disorders;
* Patients with infectious diseases;
* Pregnant or breastfeeding women, or those with suspected pregnancy;
* Patients taking bisphosphonates;
* Oncologic patients and those undergoing head and neck radiotherapy or receiving chemotherapy;
* Patients with alcohol or drug abuse.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.